חזרה לתוצאות החיפוש

Study of SGR-1505 in Mature B-Cell Neoplasms

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Mature B-Cell Neoplasm · Non Hodgkin Lymphoma · DLBCL · Waldenstrom Macroglobulinemia · MALT Lymphoma · Follicular Lymphoma · Pediatric-Type Follicular Lymphoma · IRF4 Gene Rearrangement · EBV-Positive DLBCL, Nos · Burkitt Lymphoma · Plasmablastic Lymphoma · High-grade B-cell Lymphoma · Primary Cutaneous Follicle Center Lymphoma · Primary Effusion Lymphoma · Mantle Cell Lymphoma · DLBCL Germinal Center B-Cell Type · Primary Mediastinal Large B Cell Lymphoma · T-Cell/Histiocyte Rich Lymphoma · ALK-Positive Large B-Cell Lymphoma · Primary Cutaneous Diffuse Large B-Cell Lymphoma · Splenic Marginal Zone Lymphoma · Chronic Lymphocytic Leukemia · Nodal Marginal Zone Lymphoma · HHV8-Positive DLBCL, Nos · Lymphoplasmacytic Lymphoma · Duodenal-Type Follicular Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Banner Health - MD Anderson Cancer Center, Gilbert, Arizona, United States

    Contact: Study coordinator (Bryan Crabtree) · bryan.crabtree@bannerhealth.com · 480-256-5411

  • Christiana Care Hospital - Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Denise Demaio, BSN, RN) · Denise.A.DeMaio@ChristianaCare.org · 302-623-4639

  • Napa Research, Pompano Beach, Florida, United States

    Contact: Study coordinator (Magda Hernandez) · mhernandez@napa-trials.com · 954-773-9890
    Contact: Principal Investigator (David Kahn, M.D.)

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Study coordinator · bmttrials@bidmc.harvard.edu · 617-667-9920

  • Regional Cancer Care Associates, Hackensack, New Jersey, United States

    Contact: Study coordinator (Melanie Gonzales) · melaniegonzalez@regionalcancercare.org · 732-530-8666
    Contact: Principal Investigator (Iuliana Shapira, M.D.)

  • Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

  • Weill Cornell, New York, New York, United States

  • Montefiore Medical Center, The Bronx, New York, United States

  • Duke University, Durham, North Carolina, United States

  • Gabrail Cancer & Research Center, Canton, Ohio, United States

    Contact: Study coordinator (Carrie Smith, R.N.) · CSmith@GabrailCancerCenter.com · 330-492-3345
    Contact: Principal Investigator (Nashat Gabrail, M.D.)

  • The Ohio State University - The James Cancer Hospital, Columbus, Ohio, United States

    Study coordinator · 614-366-5643
    Contact: Principal Investigator (Jennifer Woyach, MD)

  • Oregon Health and Science University - Knight Cancer Institute, Portland, Oregon, United States

    Contact: Study coordinator (Knight Clinical Trials) · trials@ohsu.edu · 503-494-1080

  • Rhode Island Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Andrew Schumacher) · aschumacher@lifespan.org
    Contact: Principal Investigator (Adam Olszewski, M.D.)

  • University of Texas Southwestern, Dallas, Texas, United States

  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Study coordinator · agopal@uw.edu · 206-606-2037
    Contact: Principal Investigator (Ajay Gopal, MD)

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Study coordinator · _cccto@mcw.edu · 414-805-8900

  • AP-HP Hôpital Henri-Mondor, Créteil, France

  • Institut Gustave Roussy, Villejuif, France

  • Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo - Presidio Ospedaliero SS Antonio e Biagio e Cesare Arrigo, Ospedale Civile, Alessandria, Italy

  • ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

  • IRCCS Ospedale San Raffaele, Milan, Italy

  • AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino, Italy

  • Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona, Italy

  • Institute of Oncology, ARENSIA Exploratory Medicine, Chisinau, Moldova

    Contact: Principal Investigator (Vasile Musteata, MD, PhD)

  • Uniwersyteckie Centrum Kliniczne, Osrodek Badan Klinicznych Wczesnych Faz, Gdansk, Poland

  • Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie, Warsaw, Poland

  • ARENSIA Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest, Romania

  • ARENSIA Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca, Cluj-Napoca, Romania

  • Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Spain

  • Hospital Universitario Quironsalud Madrid, Madrid, Spain

  • START Madrid - CIOCC, Madrid, Spain

  • START Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Spain

  • Clinica Universidad de Navarra - Pamplona, Pamplona, Spain

  • Hospital Clinico Universitario de Salamanca, Salamanca, Spain

  • ARENSIA Research Clinic at Harmony Health Clinic, Kyiv, Ukraine

מובילי המחקר

  • Frank G Basile, M.D.

    Study Director

    Schrodinger Inc.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)